Home         Forums  

Go Back   Marrowforums > Bone Marrow Failure Diseases > MDS
Register FAQ Search Today's Posts Mark Forums Read

MDS Myelodysplastic syndromes

Reply
 
Thread Tools Search this Thread
  #1  
Old Wed Feb 9, 2011, 04:43 AM
akita akita is offline
Member
 
Join Date: Nov 2010
Posts: 110
Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syn

As i understood, this is only a problem for men and when they are low-risk.

I think you should read the fulltext to get more information. This has been the first lifestyle study for MDS and they supposedly have also looked for other parameters.

Kind regards, Margarete


---
http://www.ncbi.nlm.nih.gov/pubmed/21287258

Cancer Causes Control. 2011 Feb 2. [Epub ahead of print]

Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes.

Ma X, Wang R, Galili N, Mayne ST, Wang SA, Yu H, Raza A.

Department of Epidemiology and Public Health, Yale University School of Medicine, 60 College St, Box 208034, New Haven, CT, 06520-8034, USA, xiaomei.ma@yale.edu.

Abstract

Myelodysplastic syndromes (MDS) are a group of hematological malignancies with poor survival. Although previous studies have identified the prognostic role of multiple demographic and clinical characteristics, the potential role of lifestyle factors has not been evaluated. In this study, we conducted an extensive assessment of the predictors of MDS survival, with a special focus on lifestyle factors. A total of 616 patients (median survival = 4.1 years) were included in the analysis, and multivariate Cox proportional hazard models were utilized to estimate hazard ratios. Compared with non-smokers, MDS patients who smoked at the initial clinical encounter had a significantly increased risk of death [hazard ratio (HR) = 1.46, 95% confidence intervals (CI): 1.07-2.00]. The elevated risk was restricted to men (HR = 1.76, 95% CI: 1.21-2.56) and not observed among women (HR = 0.98, 95% CI: 0.51-1.85). When patients were stratified by the IPSS categorization, a near three fold increased risk of death was associated with smoking among patients with low-risk MDS (HR = 2.83, 95% CI: 1.48-5.39), whereas smoking did not appear to influence the survival of patients with intermediate- or high-risk MDS. This study was the first to identify smoking as a significant and independent predictor of MDS survival, particularly among low-risk patients.

PMID: 21287258 [PubMed - as supplied by publisher]
__________________
Margarete, 54, living in Vienna, Austria,
MDS/AML M2, diagnosed 9/2007, then Chemos, aSZT 4/2008, chronic GVHD
Reply With Quote
  #2  
Old Wed Feb 9, 2011, 11:25 AM
Neil Cuadra Neil Cuadra is offline
Owner
 
Join Date: Jul 2006
Location: Los Angeles, California
Posts: 2,553
It's not surprising that MDS patients who are smokers are at a disadvantage, since they have an added health risk, but I find it puzzling that it applies more to lower-risk MDS than to higher-risk MDS. Perhaps smokers with higher-risk MDS are more likely to stop smoking because they're undergoing more serious treatment. But why does the increased risk apply only to men?

I think this is the proposal that led to the study. It lists these factors of study: family history, medical history, cigarette smoking, alcohol drinking, exposure to occupational and environmental chemicals, and exercise.
Reply With Quote
Reply


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
The lower risk MDS patient at risk of rapid progression akita MDS 0 Mon Dec 27, 2010 04:28 AM
New Oral Medication Gives Hope to Patients with Blood Cancer Doug Mylie Canada 0 Sat Mar 8, 2008 12:27 PM


All times are GMT -4. The time now is 01:16 AM.


Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright © 2006-2020 Marrowforums.org